Matt Maeson

Chesapeake Bay native Matt Maeson crafts a shadowy style of rock that fuses raw folk textures with polished contemporary pop arrangements. The singer/songwriter achieved his initial breakthrough via the 2017 release “Cringe,” then reached the summit of Billboard’s Alternative Songs chart with “Hallucinogenics,” a track from his first full-length effort, Bank On the Funeral, issued in 2019. During the ensuing two years he concentrated on joint ventures before launching the USERx endeavor alongside producer Rozwell in 2021. He resumed solo activity the following year with the standalone track “Blood Runs Red.”

Music entered Maeson’s life at an early stage when he picked up drums and guitar as a child, later joining his father’s prison ministry on tour. While already developing his songwriting skills amid a turbulent rebellious phase in his late teens, the encounters performing inside high-security facilities and other stark environments left a deep mark and sharpened his commitment to a career as a singer/songwriter. Blending blues-tinged indie folk with contemporary production, he uploaded material online until Atlantic’s Neon Gold Records imprint noticed him and offered a contract in 2016. That summer he launched his first headlining tour under the auspices of Communion, the organization established by Mumford & Sons’ Ben Lovett.

His opening EP, Who Killed Matt Maeson?, arrived in March 2017 through Atlantic and Neon Gold and was spearheaded by the tracks “Cringe” and “Grave Digger.” One year afterward he delivered the six-song EP The Hearse, which preceded the 2019 arrival of Bank On the Funeral. That album contained the alternative-chart-topping single “Hallucinogenics,” later reissued with guest vocals by Lana Del Rey. In 2020 Maeson assembled the USERx project with producer Rozwell, and the pair unveiled their self-titled debut in 2021. During the same period he appeared on Illenium’s Heavenly Side EP. The independent single “Blood Runs Red,” described as hypnotic and bluesy, surfaced in May 2022.